The FDA is fast-tracking a second psilocybin drug to treat depression
(Rachel Feltman/ Popular Science) —The U.S. Food and Drug Administration (FDA) has given the hallucinogenic compound psilocybin, known for giving “magic mushrooms” their mind-altering powers, a “Breakthrough Therapy” designation for the second time in just over a year.
This designation, which is designed to expedite the development …